GlaxoSmithKline (GSK) is to establish an outsourced global drug development support centre in Mumbai to help meet the demands of the growing GSK pipeline.

Under a multi-year, multi-million dollar contract signed by GSK and Tata Consultancy Services will provide a variety of services in clinical research, including clinical data management and clinical submissions support. The partnership will help GSK expand capacity in response to increased efficiency demands and benefit from cost and process improvements.

The centre will house a TCS team including pharmacologists, with PhDs in life sciences, post-graduates in Pharmacy, and individuals with a life sciences background experienced in clinical-data management and programming.

"This strategic partnership with TCS represents a significant step towards GSK's vision of leveraging key talent globally to develop innovative medicines, said Dr. Amber Salzman, GSK senior vice president of Development Operations. “I am confident our collaboration will benefit both partners and, most important, help to deliver new medicines to patients.”

GSK, whose presence in India dates from 1924, is the leading research-based pharmaceutical company in the country by sales. The pharmaceuticals business of GSK India currently employs 2,425 people.